Taiwanese Startup Leading Medical Innovation Expands into Japan

Taiwanese startups are making significant strides in addressing Japan’s critical healthcare challenges, particularly in cancer treatment, elderly care, and chronic disease management. With the support of Startup Island TAIWAN, a program sponsored by Taiwan's National Development Council (NDC), these startups are bringing innovative technologies to Japan’s healthcare system, aiming to improve both care quality and efficiency.

Japan, with one of the world’s oldest populations, faces major issues in healthcare, including providing effective medical care and managing the increasing burden of nursing care. Taiwanese startups are well-positioned to tackle these challenges, offering cutting-edge solutions tailored to the needs of Japan’s aging society.

One standout example is CancerFree Biotech, a company that has made waves in Japan with its “Avatar Medicine” technology. This innovative approach allows for personalized drug testing for cancer patients, optimizing treatment plans. CancerFree Biotech's success has been recognized internationally, having received four awards in Japan this year, including the prestigious Life Science Award and Audience Award at the Asian Entrepreneurship Awards. Their growing recognition highlights the immense potential of Taiwanese innovation in transforming healthcare systems globally, particularly in tackling complex medical challenges in Japan.

Souce：台湾発、医療の未来を切り拓くスタートアップが日本に進出（2025年1月23日）｜BIGLOBEニュース